Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00357916 · ClinicalTrials.gov registry record · Phase 1
Study to Determine the Sensitizing Potential of PEP005 Topical Gel in Healthy Volunteers Using a Repeat Insult Patch Test Design
A Phase 1 study, sponsored by Peplin.
- Completed
- Registry status
- Phase 1
- Development phase
- 200
- Enrollment target
NCT00357916 is a Phase 1 study that has completed, run by Peplin. The registered enrollment target is 200 participants.
The verdict
NCT00357916, a Phase 1 study, has completed, sponsored by Peplin.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 200 participants
- Enrollment target
Study Summary
To determine the sensitisation potential of PEP005 Topical Gel (0.01% concentration) on normal skin To evaluate skin irritation
Interventions
- DRUG PEP005 Topical Gel (0.01% concentration)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2006-06 |
| Est. Completion | 2006-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00357916
The ClinicalTrials.gov registry entry for NCT00357916 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Peplin, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PEP005 Topical Gel (0.01% concentration) is the first listed.
NCT00357916 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00357916 about?
NCT00357916 is a clinical study titled "Study to Determine the Sensitizing Potential of PEP005 Topical Gel in Healthy Volunteers Using a Repeat Insult Patch Test Design". To determine the sensitisation potential of PEP005 Topical Gel (0.01% concentration) on normal skin To evaluate skin irritation
What is the current status of trial NCT00357916?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 200 participants. The study started on 2006-06. Estimated completion is 2006-10.
What interventions are being tested in trial NCT00357916?
The interventions under investigation include: PEP005 Topical Gel (0.01% concentration) (DRUG).
Who is sponsoring clinical trial NCT00357916?
This trial is sponsored by Peplin, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.